Haloperidol Prevents Oxytosis/Ferroptosis by Targeting Lysosomal Ferrous Ions in a Manner Independent of Dopamine D2 and Sigma-1 Receptors

Yoko Hirata(Gifu University), Kyoji Furuta(Gifu University), Shotaro Yamamoto(Gifu University), Hiroshi Takemori(Gifu University), Kentaro Oh‐hashi(Innovative Research (United States)), Tasuku Hirayama(Gifu Pharmaceutical University), Kohei Oka(Fukuyama City Hospital), Hiroki Watanabe(Kanazawa University), Hideko Nagasawa(Gifu Pharmaceutical University)
ACS Chemical Neuroscience
September 1, 2022
Cited by 14


Related Papers